{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:11:18Z","timestamp":1793448678043,"version":"4.5.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Nantong Health Commission Scientific Research Project","award":["QNZ2023066"],"award-info":[{"award-number":["QNZ2023066"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,14]]},"abstract":"<jats:p>\n                    This study aims to provide a reference for clinical treatment selection by comparing noninvasive ventilation (NIV) and high-flow nasal cannula (HFNC) oxygen therapy in patients with chronic obstructive pulmonary disease (COPD) complicated by community-acquired pneumonia (CAP). From January 2022 to December 2023, 63 patients with COPD and CAP treated at our hospital were enrolled. Patients were allocated to either the NIV group (33 patients) or the HFNC group (30 patients), in addition to receiving conventional treatments. The groups were compared across various parameters including respiratory rate (RR), peripheral oxygen saturation (SpO\n                    <jats:sub>2<\/jats:sub>\n                    ), arterial oxygen partial pressure (PaO\n                    <jats:sub>2<\/jats:sub>\n                    ), oxygenation index (PaO\n                    <jats:sub>2<\/jats:sub>\n                    \/fraction of inspiration O\n                    <jats:sub>2<\/jats:sub>\n                    [FiO\n                    <jats:sub>2<\/jats:sub>\n                    ]), rates of complications, tracheal intubation, mortality, total hospital stay, and hospital costs at 1, 3, and 7 days post-treatment. After 1, 3, and 7 days of treatment, both groups exhibited significant improvements in RR, SpO\n                    <jats:sub>2<\/jats:sub>\n                    , PaO\n                    <jats:sub>2<\/jats:sub>\n                    , and PaO\n                    <jats:sub>2<\/jats:sub>\n                    \/FiO\n                    <jats:sub>2<\/jats:sub>\n                    from baseline (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). The improvements increased over time. However, no significant differences were observed between the NIV and HFNC groups in RR, SpO\n                    <jats:sub>2<\/jats:sub>\n                    , PaO\n                    <jats:sub>2<\/jats:sub>\n                    , and PaO\n                    <jats:sub>2<\/jats:sub>\n                    \/FiO\n                    <jats:sub>2<\/jats:sub>\n                    at the measured time points (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05); the HFNC group experienced lower rates of complications such as facial injuries, dry nose and mouth, and bloating (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.05). No significant differences were found in tracheal intubation rates, mortality rates, total hospital stay, and total hospital costs between the groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). Both NIV and HFNC effectively improve respiratory and circulatory parameters in patients with COPD and CAP, with similar efficacy rates. While there were no significant differences in tracheal intubation rates, mortality rates, total hospital duration, and costs, HFNC was associated with fewer complications and greater patient comfort, rendering it a more favorable clinical option.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000041829","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T15:04:10Z","timestamp":1742310250000},"page":"e41829","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Comparative study of noninvasive positive pressure ventilation and high-flow nasal cannula oxygen therapy in the treatment of patients with COPD and community-acquired pneumonia"],"prefix":"10.1097","volume":"104","author":[{"given":"Wangfei","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Nantong Third People\u2019s Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nantong Third People\u2019s Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghua","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nantong Third People\u2019s Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhui","family":"Wang","sequence":"additional","affiliation":[{"name":"The Science and Education Department, Nantong Rici Hospital, Nantong Rici Hospital Affiliated to Yangzhou University, Nantong, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0408-9599","authenticated-orcid":false,"given":"Lina","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nantong Third People\u2019s Hospital, Affiliated Nantong Hospital 3 of Nantong University, Nantong, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260108","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-med-080919-112707","article-title":"Advances in chronic obstructive pulmonary disease.","volume":"72","author":"Ferrera","year":"2021","journal-title":"Annu Rev Med"},{"key":"R2-20260108","doi-asserted-by":"crossref","first-page":"ITC17","DOI":"10.7326\/AITC202008040","article-title":"Chronic obstructive pulmonary disease.","volume":"173","author":"Labaki","year":"2020","journal-title":"Ann Intern Med"},{"key":"R3-20260108","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/jcm9010230","article-title":"Influence of pneumonia on the survival of patients with COPD.","volume":"9","author":"Ji","year":"2020","journal-title":"J Clin Med"},{"key":"R4-20260108","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000510615","article-title":"Pneumonia is associated with increased mortality in hospitalized COPD patients: a systematic review and meta-analysis.","volume":"100","author":"Yu","year":"2021","journal-title":"Respiration"},{"key":"R5-20260108","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2147\/COPD.S121389","article-title":"Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.","volume":"12","author":"Williams","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R6-20260108","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/COPD.S96179","article-title":"Incidence and outcomes of patients hospitalized with COPD exacerbation with and without pneumonia.","volume":"11","author":"Sogaard","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R7-20260108","first-page":"381","article-title":"Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People\u2019s Republic of China.","volume":"9","author":"Cai","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R8-20260108","first-page":"241","article-title":"Guidelines for the diagnosis and treatment of adult community acquired pneumonia in China (2016 Edition).","volume":"39","author":"Qu","year":"2016","journal-title":"Zhonghua Jie He He Hu Xi Za Zhi"},{"key":"R9-20260108","first-page":"1753","article-title":"Smoking-related mortality in the United States.","volume":"368","author":"Schroeder","year":"2013","journal-title":"N Engl J Med"},{"key":"R10-20260108","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/3218","article-title":"The global burden of disease, 1990-2020.","volume":"4","author":"Lopez","year":"1998","journal-title":"Nat Med"},{"key":"R11-20260108","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.rmed.2012.04.008","article-title":"The natural history of community-acquired pneumonia in COPD patients: a population database analysis.","volume":"106","author":"Mullerova","year":"2012","journal-title":"Respir Med"},{"key":"R12-20260108","doi-asserted-by":"crossref","first-page":"e0134004","DOI":"10.1371\/journal.pone.0134004","article-title":"The effect of incidental consolidation on management and outcomes in COPD exacerbations: data from the European COPD audit.","volume":"10","author":"Saleh","year":"2015","journal-title":"PLoS One"},{"key":"R13-20260108","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1159\/000327203","article-title":"U.K. National COPD Resources and Outcomes Project 2008: patients with chronic obstructive pulmonary disease exacerbations who present with radiological pneumonia have worse outcome compared to those with non-pneumonic chronic obstructive pulmonary disease exacerbations.","volume":"82","author":"Myint","year":"2011","journal-title":"Respiration"},{"key":"R14-20260108","doi-asserted-by":"crossref","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019.","volume":"53","author":"Singh","year":"2019","journal-title":"Eur Respir J"},{"key":"R15-20260108","doi-asserted-by":"crossref","first-page":"e13326","DOI":"10.5812\/ircmj.13326","article-title":"Rapid shallow breathing index survey, a predictor of non-invasive ventilation necessity in patients with chronic obstructive pulmonary disease exacerbation: an analytical descriptive prospective study.","volume":"16","author":"Soleimanpour","year":"2014","journal-title":"Iran Red Crescent Med J"},{"key":"R16-20260108","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2147\/COPD.S104616","article-title":"Nasal highflow improves ventilation in patients with COPD.","volume":"11","author":"Braunlich","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R17-20260108","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1097\/CCM.0000000000003740","article-title":"High-flow oxygen therapy after noninvasive ventilation interruption in patients recovering from hypercapnic acute respiratory failure: a physiological crossover trial.","volume":"47","author":"Longhini","year":"2019","journal-title":"Crit Care Med"},{"key":"R18-20260108","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure.","volume":"372","author":"Frat","year":"2015","journal-title":"N Engl J Med"},{"key":"R19-20260108","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1164\/rccm.202201-0199OC","article-title":"Home high-flow nasal cannula oxygen therapy for stable hypercapnic COPD: a randomized clinical trial.","volume":"206","author":"Nagata","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"R20-20260108","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.2147\/COPD.S206567","article-title":"High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study.","volume":"14","author":"Sun","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R21-20260108","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1186\/s13054-020-03214-9","article-title":"High-flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease patients after extubation: a multicenter, randomized controlled trial.","volume":"24","author":"Tan","year":"2020","journal-title":"Crit Care"},{"key":"R22-20260108","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMra1208707","article-title":"Ventilator-induced lung injury.","volume":"369","author":"Slutsky","year":"2013","journal-title":"N Engl J Med"},{"key":"R23-20260108","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4187\/respcare.04577","article-title":"High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects.","volume":"61","author":"Nishimura","year":"2016","journal-title":"Respir Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:00:38Z","timestamp":1767906038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041829","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}